Ledger.Open graph →
SEC Form D · filed July 11, 2023

MAINZ BIOMED N.V

Offering
$50.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MAINZ, 2M
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Gregory Tibbits · Mainz, 2MDirectorNicole Holden · Mainz, 2MDirectorAlberto Libanori · Mainz, 2MDirectorWilliam Caragol · Mainz, 2MExecPhillip Freese · Mainz, 2MExecMoritz Eidens · Mainz, 2MExec · DirectorHeiner Dreismann · Mainz, 2MDirectorDarin Leigh · Mainz, 2MExecHans Hekland · Mainz, 2MDirectorGuido Baechler · Mainz, 2MExec · DirectorPhillip Freese · Mainz, 2MExecGuido Baechler · Mainz, 2MExec · DirectorHans Hekland · Mainz, 2MDirectorGregory Tibbits · Mainz, 2MDirectorWilliam Caragol · Mainz, 2MExecNicole Holden · Mainz, 2MDirectorAlberto Libanori · Mainz, 2MDirectorDarin Leigh · Mainz, 2MExecHeiner Dreismann · Mainz, 2MDirectorMoritz Eidens · Mainz, 2MExec · DirectorRegina Reale · NEW YORK, NYExec · DirectorRomi Mahajan · Bellevue, WAExec · DirectorSwadesh Mahajan · Austin, TXDirectorMike Kotschenreuther · Cedar Park, TXExecChristopher C. Maguire · Dallas, TXDirectorRobert C. Dozier · Dallas, TXDirectorScott C. Harrington · Dallas, TXDirectorBrian C. Parro · Dallas, TXDirectorEllen Terchila · Vancouver, Z4ExecChristian Salem · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗